Eledon Pharmaceuticals Inc. (NASDAQ: ELDN) Stock Information | RedChip

Eledon Pharmaceuticals Inc. (NASDAQ: ELDN)


$4.2300
+0.0400 ( +1.44% ) 110.7K

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

Market Data


Open


$4.2300

Previous close


$4.1900

Volume


110.7K

Market cap


$248.52M

Day range


$3.9500 - $4.2380

52 week range


$1.5199 - $5.5400

SEC Filings


Form Type Description Pages Date
8-k 8K-related 11 Dec 20, 2024
4 Insider transactions 1 Nov 22, 2024
4 Insider transactions 1 Nov 22, 2024
4 Insider transactions 1 Nov 22, 2024
4 Insider transactions 1 Nov 22, 2024
10-q Quarterly Reports 73 Nov 12, 2024
8-k 8K-related 13 Nov 12, 2024
4 Insider transactions 1 Oct 31, 2024
8-k 8K-related 18 Oct 30, 2024
8-k 8K-related 13 Oct 29, 2024

Latest News